Guam's mystery disease offers blueprint for preventing neurodegeneration
A decades-long investigation into why ALS and Parkinson's-like disease nearly vanished from Guam reveals that identifying and removing environmental triggers may prevent neurodegenerative illness entirely—not just delay it. The finding shifts focus from treating disease after symptoms emerge to blocking it upstream, with major implications for public health strategy and pharmaceutical investment priorities.
Originaltitel: Brain health: Pathway to primary prevention of neurodegenerative disorders of environmental origin
<p>While rising global rates of neurodegenerative disease encourage early diagnosis and therapeutic intervention to block clinical expression (secondary prevention), a more powerful approach is to identify and remove environmental factors that trigger long-latencybrain disease (primary prevention) by acting on a susceptible genotype or acting alone. The latter is illustrated by the post-World War II decline and disappearance of Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex (ALS/PDC), a prototypical often-familial neurodegenerative disease formerly present in very high incidence on the island of Guam. Lessons learned from 75 years of investigation on the etiology of ALS/PDC include: the importance of focusing field research on the disease epicenter and patients with early-onset disease; soliciting exposure history from patients, family, and community to guide multidisciplinary biomedical investigation; recognition that disease phenotype may vary with exposure history, and that familial brain disease may have a primarily environmental origin. Furthermore, removal from exposure to the environmental trigger effects primary disease prevention.</p>